Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Tregopil vs Insulin Aspart in T2DM
NCT03430856Phase 3Completed
- Sponsor
- Biocon
- Start
- Dec 2017
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin tregopil in type 2 diabetes mellitus (T2DM), sponsored by Biocon. Started Dec 2017; status: completed.
02
Drugs
insulin tregopil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03430856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03430856.